Back to STATE STREET CORP STATE STREET CORP

ARWRARWR
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ARROWHEAD PHARMACEUTICALS IN

STATE STREET CORP holds 5.7M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $464.2M as of 2026-Q2. The position was decreased (-12.3% shares). ARWR represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$464.2M

Current Shares

5.7M

Total Value Change

+$341.1M

Total Shares Change

-659,691

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.7M
-12.3%
$464.2M0.0%$81.51
0
2026-Q1
Increased
6.5M
+1.4%
$407.3M0.0%$64.10
32
2025-Q4
Increased
6.4M
+0.1%
$425.2M0.0%$67.25
31
2025-Q3
Increased
6.4M
+0.4%
$220.6M0.0%$33.78
31
2025-Q2
Decreased
6.4M
-9.0%
$100.7M0.0%$16.08
0
2025-Q1
Increased
7M
+16.3%
$89.2M0.0%$13.82
35
2024-Q4
Decreased
6M
-5.3%
$113.1M0.0%$18.61
0
2024-Q3
Increased
6.4M
+8.8%
$123.1M0.0%$19.67
33

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used